# David Fabrizio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-fabrizio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,366 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 38 |
| i10-index | 70 |
| Last Known Institution | Editas Medicine (United States) |
| OpenAlex ID | https://openalex.org/A5002641296 |
| ORCID iD | https://orcid.org/0000-0001-8088-9476 |
| Works | 202 |

## Researcher papers

- [Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden](https://scholariq.org/papers/analysis-of-100-000-human-cancer-genomes-reveals-the-landscape-of-tumor/)
- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project](https://scholariq.org/papers/establishing-guidelines-to-harmonize-tumor-mutational-burden-tmb-in-silico/)
- [Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade](https://scholariq.org/papers/targeted-next-generation-sequencing-identifies-markers-of-response-to-pd-1/)
- [Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population](https://scholariq.org/papers/genomic-context-of-ntrk1-2-3-fusion-positive-tumours-from-a-large-real-world/)
- [Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project](https://scholariq.org/papers/aligning-tumor-mutational-burden-tmb-quantification-across-diagnostic-platforms/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

## Researcher university

- [Editas Medicine (United States)](https://scholariq.org/institutions/editas-medicine-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.